Status:
COMPLETED
M-Health Care for Patients After AMI on Disease Perception, Self-Efficacy, Anxiety and Cardio-Respiratory Fitness
Lead Sponsor:
National Defense Medical Center, Taiwan
Conditions:
Mobile Health
Acute Myocardial Infarction
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
The aim of this study is to explore the overall effectiveness of interventions using mobile health care to improve disease perception, self-efficacy, anxiety, cardio-pulmonary fitness for patients wit...
Detailed Description
Heart disease is the second leading cause of death in Taiwan. Coronary artery disease (CAD) is the majority, and coronary artery disease is the most common cardiovascular disease. There is an increase...
Eligibility Criteria
Inclusion
- Taiwanese, understand Chinese
- Patients who are over 20 years old and have AMI (including ST segment ascending and non-ST segment ascending), diagnosed by percutaneous coronary intervention and without complications within 30±5 days, the left ventricular injection rate is greater than 40% .
- Ability and willingness to provide informed consent.
- Have a smartphone.
- Can receive and send smartphone messages.
Exclusion
- Those who can't express their wishes clearly (such as mental dysfunction)
- mental disorder
- Patients who participate in other research projects
- Planned coronary artery bypass surgery or other diseases that require continuous heart care.
- Abuse of alcohol or narcotics.
- Left ventricular ejection fraction (LVEF) is less than 40%.
Key Trial Info
Start Date :
July 22 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 20 2022
Estimated Enrollment :
31 Patients enrolled
Trial Details
Trial ID
NCT04438356
Start Date
July 22 2020
End Date
March 20 2022
Last Update
September 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
TSGH
Taipei, Taiwan